• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类结直肠癌的独特尿液代谢生物标志物。

Distinct Urinary Metabolic Biomarkers of Human Colorectal Cancer.

机构信息

Department of Gastrointestinal Surgery, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, 518020 Guangdong, China.

Department of General Surgery, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, 518020 Guangdong, China.

出版信息

Dis Markers. 2022 Apr 26;2022:1758113. doi: 10.1155/2022/1758113. eCollection 2022.

DOI:10.1155/2022/1758113
PMID:35521635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9064491/
Abstract

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers with high mortality rate due to its poor diagnosis in the early stage. Here, we report a urinary metabolomic study on a cohort of CRC patients ( =67) and healthy controls ( =21) using ultraperformance liquid chromatography triple quadrupole mass spectrometry. Pathway analysis showed that a series of pathways that belong to amino acid metabolism, carbohydrate metabolism, and lipid metabolism were dysregulated, for instance the glycine, serine and threonine metabolism, alanine, aspartate and glutamate metabolism, glyoxylate and dicarboxylate metabolism, glycolysis, and TCA cycle. A total of 48 differential metabolites were identified in CRC compared to controls. A panel of 12 biomarkers composed of chenodeoxycholic acid, vanillic acid, adenosine monophosphate, glycolic acid, histidine, azelaic acid, hydroxypropionic acid, glycine, 3,4-dihydroxymandelic acid, 4-hydroxybenzoic acid, oxoglutaric acid, and homocitrulline were identified by Random Forest (RF), Support Vector Machine (SVM), and Boruta analysis classification model and validated by Gradient Boosting (GB), Logistic Regression (LR), and Random Forest diagnostic model, which were able to discriminate CRC subjects from healthy controls. These urinary metabolic biomarkers provided a novel and promising molecular approach for the early diagnosis of CRC.

摘要

结直肠癌(CRC)是最常见的癌症之一,由于其早期诊断不佳,死亡率很高。在这里,我们报告了一项使用超高效液相色谱三重四极杆质谱对 CRC 患者( =67)和健康对照( =21)进行的尿液代谢组学研究。途径分析显示,一系列属于氨基酸代谢、碳水化合物代谢和脂质代谢的途径发生了失调,例如甘氨酸、丝氨酸和苏氨酸代谢、丙氨酸、天冬氨酸和谷氨酸代谢、乙醛酸和二羧酸代谢、糖酵解和 TCA 循环。与对照组相比,CRC 中总共鉴定出 48 种差异代谢物。通过随机森林(RF)、支持向量机(SVM)和 Boruta 分析分类模型,确定了由鹅去氧胆酸、香草酸、单磷酸腺苷、乙二醇酸、组氨酸、壬二酸、羟基丙酸、甘氨酸、3,4-二羟苯乙酸、4-羟基苯甲酸、草酰乙酸和同型瓜氨酸组成的 12 个生物标志物面板,通过梯度提升(GB)、逻辑回归(LR)和随机森林诊断模型进行验证,这些模型能够区分 CRC 患者和健康对照者。这些尿液代谢生物标志物为 CRC 的早期诊断提供了一种新颖且有前途的分子方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aea/9064491/95d14dbd7c3d/DM2022-1758113.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aea/9064491/33a625af4520/DM2022-1758113.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aea/9064491/6129c95f4652/DM2022-1758113.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aea/9064491/aa9b1d73688e/DM2022-1758113.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aea/9064491/908c378adf5e/DM2022-1758113.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aea/9064491/7a2f440daff0/DM2022-1758113.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aea/9064491/95d14dbd7c3d/DM2022-1758113.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aea/9064491/33a625af4520/DM2022-1758113.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aea/9064491/6129c95f4652/DM2022-1758113.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aea/9064491/aa9b1d73688e/DM2022-1758113.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aea/9064491/908c378adf5e/DM2022-1758113.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aea/9064491/7a2f440daff0/DM2022-1758113.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aea/9064491/95d14dbd7c3d/DM2022-1758113.006.jpg

相似文献

1
Distinct Urinary Metabolic Biomarkers of Human Colorectal Cancer.人类结直肠癌的独特尿液代谢生物标志物。
Dis Markers. 2022 Apr 26;2022:1758113. doi: 10.1155/2022/1758113. eCollection 2022.
2
Distinct urinary metabolic profile of human colorectal cancer.人类结直肠癌的独特尿液代谢特征。
J Proteome Res. 2012 Feb 3;11(2):1354-63. doi: 10.1021/pr201001a. Epub 2011 Dec 28.
3
[Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].[血清非靶向代谢组学与靶向胆汁酸代谢组学的综合分析用于鉴定结直肠癌诊断生物标志物]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Mar 20;43(3):443-453. doi: 10.12122/j.issn.1673-4254.2023.03.15.
4
Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.代谢组学分析鉴定出结直肠癌的血清代谢物生物标志物及相关代谢途径。
Dis Markers. 2021 Dec 7;2021:6858809. doi: 10.1155/2021/6858809. eCollection 2021.
5
Metabonomics identifies serum metabolite markers of colorectal cancer.代谢组学鉴定结直肠癌的血清代谢物标志物。
J Proteome Res. 2013 Jun 7;12(6):3000-9. doi: 10.1021/pr400337b. Epub 2013 May 29.
6
Urinary charged metabolite profiling of colorectal cancer using capillary electrophoresis-mass spectrometry.采用毛细管电泳-质谱联用技术对结直肠癌进行尿液带电代谢产物分析。
Sci Rep. 2020 Dec 3;10(1):21057. doi: 10.1038/s41598-020-78038-2.
7
Serum amino acid metabolic profiles of ankylosing spondylitis by targeted metabolomics analysis.基于靶向代谢组学分析的强直性脊柱炎血清氨基酸代谢特征。
Clin Rheumatol. 2020 Aug;39(8):2325-2336. doi: 10.1007/s10067-020-04974-z. Epub 2020 Mar 4.
8
Plasma metabolomic differences in early-onset compared to average-onset colorectal cancer.与普通发病相比,早发性结直肠癌的血浆代谢组学差异。
Sci Rep. 2024 Feb 21;14(1):4294. doi: 10.1038/s41598-024-54560-5.
9
Ultra‑performance liquid chromatography coupled with quadrupole time‑of‑flight mass spectrometry‑based metabolic profiling of human serum prior to and following radical resection of colorectal carcinoma.基于四极杆飞行时间质谱的超高效液相色谱法对人大肠癌根治术前和术后血清进行代谢谱分析
Mol Med Rep. 2015 Nov;12(5):6879-86. doi: 10.3892/mmr.2015.4289. Epub 2015 Sep 3.
10
Specificity of metabolic colorectal cancer biomarkers in serum through effect size.通过效应大小分析血清中代谢性结直肠癌生物标志物的特异性。
Metabolomics. 2020 Aug 13;16(8):88. doi: 10.1007/s11306-020-01707-w.

引用本文的文献

1
Plasma metabolomic differences in early-onset compared to average-onset colorectal cancer.与普通发病相比,早发性结直肠癌的血浆代谢组学差异。
Sci Rep. 2024 Feb 21;14(1):4294. doi: 10.1038/s41598-024-54560-5.
2
Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer.用于早期诊断的新型生物标志物及酪氨酸激酶抑制剂在结直肠癌中的靶向治疗。
Front Pharmacol. 2023 Sep 1;14:1189799. doi: 10.3389/fphar.2023.1189799. eCollection 2023.
3
Retracted: Distinct Urinary Metabolic Biomarkers of Human Colorectal Cancer.

本文引用的文献

1
Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.代谢组学分析鉴定出结直肠癌的血清代谢物生物标志物及相关代谢途径。
Dis Markers. 2021 Dec 7;2021:6858809. doi: 10.1155/2021/6858809. eCollection 2021.
2
A Metabolite Array Technology for Precision Medicine.一种用于精准医学的代谢物阵列技术。
Anal Chem. 2021 Apr 13;93(14):5709-5717. doi: 10.1021/acs.analchem.0c04686. Epub 2021 Apr 2.
3
IP4M: an integrated platform for mass spectrometry-based metabolomics data mining.IP4M:基于质谱的代谢组学数据挖掘的集成平台。
撤回:人类结直肠癌独特的尿液代谢生物标志物。
Dis Markers. 2023 Jul 12;2023:9873530. doi: 10.1155/2023/9873530. eCollection 2023.
4
Untargeted urinary metabolomics for bladder cancer biomarker screening with ultrahigh-resolution mass spectrometry.基于超高分辨质谱的膀胱癌生物标志物筛选的非靶向性尿液代谢组学。
Sci Rep. 2023 Jun 16;13(1):9802. doi: 10.1038/s41598-023-36874-y.
5
Small molecule metabolites: discovery of biomarkers and therapeutic targets.小分子代谢物:生物标志物和治疗靶点的发现。
Signal Transduct Target Ther. 2023 Mar 20;8(1):132. doi: 10.1038/s41392-023-01399-3.
6
Metabolic Changes and Their Associations with Selected Nutrients Intake in the Group of Workers Exposed to Arsenic.砷暴露工人组的代谢变化及其与特定营养素摄入的关联。
Metabolites. 2023 Jan 1;13(1):70. doi: 10.3390/metabo13010070.
BMC Bioinformatics. 2020 Oct 7;21(1):444. doi: 10.1186/s12859-020-03786-x.
4
Metabolomics Analysis in Serum from Patients with Colorectal Polyp and Colorectal Cancer by H-NMR Spectrometry.基于氢核磁共振波谱的结直肠息肉和结直肠癌患者血清代谢组学分析。
Dis Markers. 2019 Apr 7;2019:3491852. doi: 10.1155/2019/3491852. eCollection 2019.
5
Control of metabolism by p53 - Cancer and beyond.p53 对代谢的控制——癌症及其他。
Biochim Biophys Acta Rev Cancer. 2018 Aug;1870(1):32-42. doi: 10.1016/j.bbcan.2018.06.001. Epub 2018 Jun 5.
6
Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review.代谢组学在结直肠癌诊断、预后、生存及复发中的生物标志物发现:一项系统综述
Oncotarget. 2017 May 23;8(21):35460-35472. doi: 10.18632/oncotarget.16727.
7
Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: the ColoCare study.代谢组学和转录组学确定结直肠癌患者内脏脂肪组织和皮下脂肪组织之间的通路差异:ColoCare研究。
Am J Clin Nutr. 2015 Aug;102(2):433-43. doi: 10.3945/ajcn.114.103804. Epub 2015 Jul 8.
8
Colorectal cancer detection using targeted serum metabolic profiling.利用靶向血清代谢谱分析检测结直肠癌
J Proteome Res. 2014 Sep 5;13(9):4120-30. doi: 10.1021/pr500494u. Epub 2014 Aug 15.
9
Wnt meets Warburg: another piece in the puzzle?Wnt与瓦伯格效应:拼图中的另一块?
EMBO J. 2014 Jul 1;33(13):1420-2. doi: 10.15252/embj.201488785. Epub 2014 May 19.
10
A distinct metabolic signature of human colorectal cancer with prognostic potential.具有预后潜力的人类结直肠癌独特代谢特征。
Clin Cancer Res. 2014 Apr 15;20(8):2136-46. doi: 10.1158/1078-0432.CCR-13-1939. Epub 2014 Feb 13.